Search
Powered By HealthLine
Health Tools
 Arthritis Questions and Answers
 Arthritis Symptom Checker
 Arthritis Drug Information
 Preventing Arthritis
 Arthritis Treatment
Featured Conditions
 Osteoarthritis
 Chronic Pain
 Rheumatoid Arthritis
 Diet & Exercise
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
Drug DescriptionSide Effects & Drug InteractionsWarnings & PrecautionsAdditional Info
Clinical PharmacologyOverdosage & ContraindicationsIndications & DosagePatient Info

Cefzil

[Cefprozil]

SKIN AND SKIN STRUCTURE

Uncomplicated Skin and Skin-Structure Infections caused by Staphylococcus aureus (including penicillinase-producing strains) and Streptococcus pyogenes.

Abscesses usually require surgical drainage.

To reduce the development of drug-resistant bacteria and maintain the effectiveness of CEFZIL and other antibacterial drugs, CEFZIL should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemi-ology and susceptibility patterns may contribute to the empiric selection of therapy.

Text Continues Below



DOSAGE AND ADMINISTRATION CEFZIL

(cefprozil) is administered orally.

Dosage Duration Population/ Infection (mg) (days)
ADULTS (13 years and older)

UPPER RESPIRATORY TRACT

Pharyngitis / Tonsillitis 500 q24h 10 a
Acute Sinusitis 250 q12h or 10
(For moderate to severe infections, 500 q12h
the higher dose should be used)

LOWER RESPIRATORY TRACT

Secondary Bacterial Infection 500 q12h 10
of Acute Bronchitis and Acute
Bacterial Exacerbation of Chronic
Bronchitis

SKIN AND SKIN STRUCTURE

Uncomplicated Skin and 250 q12h or 10
Skin Structure Infections 500 q24h or
500 q12h

CHILDREN (2 years -12 years)

UPPER RESPIRATORY TRACT b
Pharyngitis / Tonsillitis 7.5 mg/ kg 10 a
q12h

SKIN AND SKIN STRUCTURE b
Uncomplicated Skin and 20 mg/ kg 10
Skin Structure Infections q24h

INFANTS & CHILDREN (6 months -12 years)

UPPER RESPIRATORY TRACT b
Otitis Media 15 mg/ kg 10
(See INDICATIONS AND USAGE q12h
and CLINICAL STUDIES)
Acute Sinusitis 7.5 mg/ kg 10
(For moderate to severe infections, q12h or
the higher dose should be used) 15 mg/ kg
a In the treatment of infections due to Streptococcus pyogenes, CEFZIL should be administered for at least 10 days. b
Not to exceed recommended adult doses. Clinitest ® and Clinistix ® are registered trademarks of Bayer HealthCare LLC.

Page:  << Prev | 1 | 2 | 3 | 4 | 5 | Next >>







HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2013. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire